BioPharma
GSK Licences COPD Drug from Empirico for $85 Million Upfront
In just a space of 24 hours, GSK, in its second pipeline-expanding deal, has gone on to license the rights to a drug for chronic...
BioPharma
CDMO Market for AAV Therapies to Hit $2.566 Billion By 2033
With a focus on Adeno-Associated Virus (AAV), the worldwide market for Contract Development and Manufacturing Organizations (CDMMOs) that biomanufacture cell and gene therapies has shown...
BioPharma
Pharmaceutical CMO Market is Set for a 7.29% CAGR by 2028
It is projected that the market for pharmaceutical contract manufacturing organizations (CMOs) would expand at a compound annual growth rate (CAGR) of 7.29 percent until...
BioPharma
Global CDMO Market for Cell and Gene Therapy Expands Rapidly
During the period of time from 2023 to 2029, the global market for cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services is...
BioPharma
CDMOs Must Reorganize to Maximize Revenue and Competitiveness
Pharmaceutical businesses increasingly outsource their product development and manufacture to Contract Development and manufacture Organizations (CDMOs), which operate in a fragmented sector that is experiencing...
BioPharma
Thermo Fisher to Acquire Clario Holdings for $8.9bn
Thermo Fisher to acquire Clario Holdings, the clinical trial data firm, for $8.9 billion in cash is in news and the same has been announced by...
BioPharma
J&J To Be in Sync with Trump Administration as MFN Spreads
As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S. policy...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.